GlassScriptPhysician profile
Caleb Saint Jean
NPI 1942650924
$5,854.21
in general payments reported to CMS, 2019-2025
17 companies · $1,094 in 2025
The $1,094 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $910 · 2020: $88.85 · 2021: $36.39 · 2022: $530 · 2023: $1,014 · 2024: $2,181 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,097 · Travel and Lodging: $1,011 · Entertainment: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,096.65 |
| Travel and Lodging | $1,011.15 |
| Entertainment | $181.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,225.35 | 2022-2025 | Total30, Precision7, Dailies |
| Coopervision INC. | $1,065.77 | 2020-2025 | Myday Contact Lens, Cvi Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $826.85 | 2019 | |
| Bausch & Lomb Americas INC. | $461.39 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Abbvie INC. | $212.94 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $204.97 | 2019-2023 | Acuvue |
| Optos, INC. | $181.30 | 2023-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Rxsight INC | $160.76 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Horizon Therapeutics Plc | $120.69 | 2023 | Tepezza |
| Biotissue Holdings INC. | $110.75 | 2025 | |
| Topcon Healthcare, INC. | $102.98 | 2024 | |
| Sun Pharmaceutical Industries INC. | $71.35 | 2019 | |
| Abb Con-Cise Optical Group LLC | $30.52 | 2023 | Spectacle Lenses, Contact Lens |
| Dompe US, INC. | $29.99 | 2025 | Oxervate |
| Astellas Pharma US INC | $27.82 | 2024 | Izervay |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $12.76 | 2020 | |
| Tearlab Corp | $8.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Saint Jean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.